689彩票邀请码

Biotechnology Value Fund

COMPARE

Overview

Number of Exits 20
CB Rank (Investor) 4,473
Biotechnology Value Fund
Biotechnology Value Fund, L.P. is an evergreen fund specializing in early stage financing. It focuses on undervalued investment
Industries  Biotechnology, Venture CapitalHeadquarters Regions  San Francisco Bay Area, West Coast, Western USFounded Date 1993Operating Status ActiveNumber of Employees 1-10Also Known As BVF PartnersChild Hubs  Biotechnology Value Fund Portfolio Companies
Investor Type  Venture Capital Investment Stage  Early Stage Venture Number of Exits 20
Website Contact Email info@bvflp.comPhone Number (312)506-6479

Biotechnology Value Fund is a San Francisco-based private investment partnership specializing in fundamentally-driven public biotechnology investments.

689彩票邀请码Since its inception in 1993, BVF has strived to build concentrated, long-term investments in small-cap biotechnology companies while performing rigorous diligence and on-going monitoring of its investments.

BVF is committed to working with its portfolio companies as partners in their successes.

Read More

689彩票邀请码 Unlock Charts on Crunchbase

Charts can be found on various organization profiles and on Hubs pages, based on data availability.

Lists Featuring This Company

Early Stage Venture Investors with Investments in Western US
5,350 Number of Organizations ● $16.9B Total Funding Amount ● 665 Number of Investors
Venture Capital Investors with Investments in Utrecht, Utrecht
53 Number of Organizations ● $63.3M Total Funding Amount ● 2 Number of Investors
San Francisco Investors
1,535 Number of Organizations ● $65.3B Total Funding Amount ● 2,123 Number of Investors
Early Stage Venture Investors with Investments in Silicon Valley
3,091 Number of Organizations ● $15B Total Funding Amount ● 430 Number of Investors

Investments

Number of Investments 31
Number of Lead Investments 11
Biotechnology Value Fund has made 31 investments. Their most recent investment was on Mar 12, 2020, when Kymera Therapeutics raised $102M.

Exits

Number of Exits 20
Biotechnology Value Fund has had 20 exits. Biotechnology Value Fund's most notable exits include EvotecBlueprint Medicines, and Prevail Therapeutics.
Evotec
Evotec is a drug discovery alliance and development partnership company.
Blueprint Medicines
Blueprint Medicines engages in the discovery and development of highly selective kinase inhibitors for genomically defined cancer subsets.
Prevail Therapeutics
Prevail Therapeutics is a biotechnology company.
Peloton Therapeutics
Peloton Therapeutics, a biotech company based in Dallas, is involved in discovering and developing novel drugs for cancer treatments.
Arcus Biosciences
Arcus Biosciences is a biotech company that visions to create new cancer therapeutics through the use of emerging insights in immunology.
IDEAYA Biosciences
IDEAYA Biosciences is an oncology-focused biotechnology company committed to the discovery of breakthrough synthetic lethality
Syndax Pharmaceuticals
Syndax Pharmaceuticals is focused on developing an HDAC inhibitor for solid tumors and hematological tumors.
Molecular Templates
Molecular Templates develops novel therapeutic compounds for cancer.
Phathom Pharmaceuticals
Phathom Pharmaceuticals is a biopharmaceutical company.
Pieris Pharmaceuticals
Pieris Pharmaceuticals, Inc. is a clinical-stage biotechnology company applying its proprietary.

Funds Raised

Number of Funds 1
Biotechnology Value Fund has raised a single venture fund, Biotechnology Value Fund II.
Announced Date  
Fund Name  
Money Raised  
Oct 8, 2008
Biotechnology Value Fund II

Current Team

Number of Current Team Members 5
Biotechnology Value Fund has 5 current team members, including Portfolio Manager Matthew Perry.
Matthew Perry
Portfolio Manager
Spike Loy
Managing Director
Kanishka Pothula
Managing Director
Mitchell Kaye
Business & Operations

Website Tech Stack by BuiltWith

Biotechnology Value Fund is actively using 7 technologies for its website. These include Viewport MetaIPhone / Mobile Compatible, and SPF.

Web Traffic by SimilarWeb

Biotechnology Value Fund is ranked 8,791,718 among websites globally based on its 1,367 monthly web visitors.

Recent News & Activity

Number of Articles 7

Related Hubs

Sign up for a free Crunchbase account to follow and track profiles you care about.


|| Sitemap | ? 2020 Crunchbase Inc. All Rights Reserved. (2b5d7be 198)
7072彩票开户 7073彩票地址 689彩票邀请码 7073彩票网址 963彩票开户 8炫彩彩票app 7073彩票注册 677彩票开户 66顺彩票app 7073彩票登录